Janssen Pharmaceuticals must pay $124.3 million of $327 million awarded by a Spartanburg jury in a case involving the antipsychotic drug Risperdal.
Janssen Pharmaceuticals must pay $124.3 million of $327 million awarded by a Spartanburg jury in a case involving the antipsychotic drug Risperdal.
Janssen Pharmaceuticals must pay $124.3 million of $327 million awarded by a Spartanburg jury in a case involving the antipsychotic drug Risperdal.